These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30517862)

  • 1. Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity.
    Vincent BM; Tardiff DF; Piotrowski JS; Aron R; Lucas MC; Chung CY; Bacherman H; Chen Y; Pires M; Subramaniam R; Doshi DB; Sadlish H; Raja WK; Solís EJ; Khurana V; Le Bourdonnec B; Scannevin RH; Rhodes KJ
    Cell Rep; 2018 Dec; 25(10):2742-2754.e31. PubMed ID: 30517862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment.
    Fanning S; Haque A; Imberdis T; Baru V; Barrasa MI; Nuber S; Termine D; Ramalingam N; Ho GPH; Noble T; Sandoe J; Lou Y; Landgraf D; Freyzon Y; Newby G; Soldner F; Terry-Kantor E; Kim TE; Hofbauer HF; Becuwe M; Jaenisch R; Pincus D; Clish CB; Walther TC; Farese RV; Srinivasan S; Welte MA; Kohlwein SD; Dettmer U; Lindquist S; Selkoe D
    Mol Cell; 2019 Mar; 73(5):1001-1014.e8. PubMed ID: 30527540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson's Disease.
    Tardiff DF; Lucas M; Wrona I; Chang B; Chung CY; Le Bourdonnec B; Rhodes KJ; Scannevin RH
    Mol Neurobiol; 2022 Apr; 59(4):2171-2189. PubMed ID: 35060064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor.
    Terry-Kantor E; Tripathi A; Imberdis T; LaVoie ZM; Ho GPH; Selkoe D; Fanning S; Ramalingam N; Dettmer U
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy.
    Kula J; Kuter KZ
    Neuropharmacology; 2024 May; 249():109865. PubMed ID: 38342377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase.
    Imberdis T; Negri J; Ramalingam N; Terry-Kantor E; Ho GPH; Fanning S; Stirtz G; Kim TE; Levy OA; Young-Pearse TL; Selkoe D; Dettmer U
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20760-20769. PubMed ID: 31548371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis.
    Tripathi A; Alnakhala H; Terry-Kantor E; Newman A; Liu L; Imberdis T; Fanning S; Nuber S; Ramalingam N; Selkoe D; Dettmer U
    J Neurosci; 2022 Mar; 42(10):2116-2130. PubMed ID: 35086904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity.
    Nuber S; Chung CY; Tardiff DF; Bechade PA; McCaffery TD; Shimanaka K; Choi J; Chang B; Raja W; Neves E; Burke C; Jiang X; Xu P; Khurana V; Dettmer U; Fanning S; Rhodes KJ; Selkoe DJ; Scannevin RH
    Neurotherapeutics; 2022 Apr; 19(3):1018-1036. PubMed ID: 35445353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
    Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
    Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.
    Hellemans KH; Hannaert JC; Denys B; Steffensen KR; Raemdonck C; Martens GA; Van Veldhoven PP; Gustafsson JA; Pipeleers D
    PLoS One; 2009 Sep; 4(9):e7266. PubMed ID: 19787047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.
    Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S
    Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered fatty acid metabolism and reduced stearoyl-coenzyme a desaturase activity in asthma.
    Rodriguez-Perez N; Schiavi E; Frei R; Ferstl R; Wawrzyniak P; Smolinska S; Sokolowska M; Sievi NA; Kohler M; Schmid-Grendelmeier P; Michalovich D; Simpson KD; Hessel EM; Jutel M; Martin-Fontecha M; Palomares O; Akdis CA; O'Mahony L
    Allergy; 2017 Nov; 72(11):1744-1752. PubMed ID: 28397284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Yeast to Humans: Leveraging New Approaches in Yeast to Accelerate Discovery of Therapeutic Targets for Synucleinopathies.
    Piotrowski JS; Tardiff DF
    Methods Mol Biol; 2019; 2049():419-444. PubMed ID: 31602625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stearoyl-CoA desaturase activity in bovine cumulus cells protects the oocyte against saturated fatty acid stress.
    Aardema H; van Tol HTA; Wubbolts RW; Brouwers JFHM; Gadella BM; Roelen BAJ
    Biol Reprod; 2017 May; 96(5):982-992. PubMed ID: 28486699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From yeast to patient neurons and back again: powerful new discovery platform.
    Tardiff DF; Khurana V; Chung CY; Lindquist S
    Mov Disord; 2014 Sep; 29(10):1231-40. PubMed ID: 25131316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.
    Iwai T; Kume S; Chin-Kanasaki M; Kuwagata S; Araki H; Takeda N; Sugaya T; Uzu T; Maegawa H; Araki SI
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the stearoyl-CoA desaturase system in octadecenoate metabolism in the Morris hepatoma 7288C.
    Zoeller RA; Wood R
    Biochim Biophys Acta; 1985 Jun; 845(3):380-8. PubMed ID: 2860925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity.
    Poudyal H; Brown L
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):217-31. PubMed ID: 21831035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.